Atlas Trials

Pathological Complete Response

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pathological Complete Response

RecordFirmDate
Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma (NCT07127497)The First Affiliated Hospital of Anhui Medical University2022-06-01
Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy (NCT04848454)Peking University First Hospital2021-11-20
THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy (NCT04815694)Fondazione Policlinico Universitario Agostino Gemelli IRCCS2021-03-17
Predicting Pathological Complete Response in Esophageal Squamous Cell Carcinoma Using a Multimodal Model Integrating Clinical, Radiomics, and Deep Learning Features (NCT07181850)Nanjing Medical University2019-01-01
Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial (NCT03038256)Peking University People's Hospital2018-01-31
Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy (NCT03349177)Zhiyong Yu2017-11-27
RISAS Procedure in Node Positive Breast Cancer Following NAC (NCT02800317)Erasmus Medical Center2017-03-30
DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer (NCT02126449)Leiden University Medical Center2014-02-01
Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade (NCT06630481)Seoul National University Hospital2009-01-01

Track Pathological Complete Response automatically

Every clearance here is in the API, with alerts when new ones post.